London [UK], November 24 (ANI): People with diabetes and eye disease have a five-fold increased risk of requiring intubation when hospitalised with COVID-19, suggest the findings of a new study.
Washington [US], October 31 (ANI): Cognitive disorders, dementia are likely to be the risk factors for developing severe COVID-19, according to research from the University of Georgia. The findings highlight the need for special care for populations with these pre-existing conditions during
Washington [US], October 28 (ANI): Dementia and other cognitive disorders are likely to be risk factors for developing severe COVID-19, according to research from the University of Georgia. The findings highlight the need for special care for populations with these pre-existing conditions du
Washington [US], October 25 (ANI): Researchers suggested that people who show severe COVID-19 infection might shed the virus and hence be infectious for as long as 20 days.
London [England], October 9 (ANI): Patients of Black ethnicity have an increased risk of requiring hospital admission for COVID-19, while patients of Asian ethnicity have an increased risk of dying in hospital from COVID-19, compared to White patients, a study has found.
New Delhi [India], October 6 (ANI): There is no benefit of plasma therapy is arresting mortality in moderate to severe cases of Covid-19, Director General of Indian Council of Medical Research, Balram Bhargava said on Tuesday.
Gurugram (Haryana) [India], September 2 (ANI/NewsVoir): An active professional from Ghaziabad was amongst the small percentage of the population infected with severe COVID-19 being treated at the critical unit of Artemis Hospitals, Gurugram. With each passing day, it became difficult for him
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe COVID-19 patients, the Union Health Ministry has decided not to include the drug in the national treatment protocol for co
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
Mumbai (Maharashtra) [India], June 29 (ANI): Maharashtra Chief Minister Uddhav Thackeray on Monday inaugurated 'Project PLATINA', world's largest convalescent plasma therapy trial cum treatment of severe COVID-19 patients.